The statement provides information for healthcare providers on genetic testing, including risks and benefits, as patients may require testing to help confirm a diagnosis or guide therapy.
The statement discusses the importance of genetic counseling before and after genetic testing and outlines potential limitations of testing in dyslipidemia. It also has a detailed table of recommendations to guide healthcare professionals.
The article, "Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association," is in press with the Journal of Clinical Lipidology and can be accessed through the journal or on the NLA website.
Copyright © 2020 LabPulse.com